{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:49:30Z","timestamp":1758440970008,"version":"3.44.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,19]]},"DOI":"10.7759\/cureus.92748","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T02:23:43Z","timestamp":1758335023000},"source":"Crossref","is-referenced-by-count":0,"title":["Autoimmune-Associated Livedoid Vasculopathy: Response to Immunomodulatory Therapy"],"prefix":"10.7759","author":[{"given":"Thanda","family":"Aung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenice X","family":"Cheah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.07.019","article-title":"Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach","volume":"69","author":"Alavi A","year":"2013","unstructured":"Alavi A, Hafner J, Dutz JP, et al.. Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach. J Am Acad Dermatol. 2013, 69:1033-1042.e1. 10.1016\/j.jaad.2013.07.019","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.993515","article-title":"A comprehensive review on pathogenesis, associations, clinical findings, and treatment of livedoid vasculopathy","volume":"9","author":"Segu\u00ed M","year":"2022","unstructured":"Segu\u00ed M, Llamas-Velasco M. A comprehensive review on pathogenesis, associations, clinical findings, and treatment of livedoid vasculopathy. Front Med (Lausanne). 2022, 9:993515. 10.3389\/fmed.2022.993515","journal-title":"Front Med (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.183635","article-title":"Livedoid vasculopathy: a review of pathogenesis and principles of management","volume":"82","author":"Vasudevan B","year":"2016","unstructured":"Vasudevan B, Neema S, Verma R. Livedoid vasculopathy: a review of pathogenesis and principles of management. Indian J Dermatol Venereol Leprol. 2016, 82:478-88. 10.4103\/0378-6323.183635","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1711","article-title":"Livedoid vasculopathy: clinical features and treatment in 24 Chinese patients","volume":"94","author":"Feng S","year":"2014","unstructured":"Feng S, Su W, Jin P, Shao C. Livedoid vasculopathy: clinical features and treatment in 24 Chinese patients. Acta Derm Venereol. 2014, 94:574-8. 10.2340\/00015555-1711","journal-title":"Acta Derm Venereol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ced\/llae023","article-title":"Associations between coagulation factors and livedoid vasculopathy and the efficacy and safety of rivaroxaban in patients with livedoid vasculopathy: a retrospective study","volume":"49","author":"Zhao C","year":"2024","unstructured":"Zhao C, Yu M, Cheng X, Li S, Feng S. Associations between coagulation factors and livedoid vasculopathy and the efficacy and safety of rivaroxaban in patients with livedoid vasculopathy: a retrospective study. Clin Exp Dermatol. 2024, 49:817-24. 10.1093\/ced\/llae023","journal-title":"Clin Exp Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.1803","article-title":"Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: successful treatment with intravenous immunoglobulin and warfarin","volume":"6","author":"Yoshioka K","year":"2018","unstructured":"Yoshioka K, Tateishi C, Kato H, Chen KR. Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: successful treatment with intravenous immunoglobulin and warfarin. Clin Case Rep. 2018, 6:2045-7. 10.1002\/ccr3.1803","journal-title":"Clin Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13997","article-title":"The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban","volume":"57","author":"Franco Marques G","year":"2018","unstructured":"Franco Marques G, Criado PR, Alves Batista Morita TC, Cajas Garc\u00eda MS. The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban. Int J Dermatol. 2018, 57:732-41. 10.1111\/ijd.13997","journal-title":"Int J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.4374","article-title":"Treatment for livedoid vasculopathy: a systematic review","volume":"154","author":"Micieli R","year":"2018","unstructured":"Micieli R, Alavi A. Treatment for livedoid vasculopathy: a systematic review. JAMA Dermatol. 2018, 154:193-202. 10.1001\/jamadermatol.2017.4374","journal-title":"JAMA Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.05.003","article-title":"Pulsed intravenous immunoglobulin therapy in livedoid vasculitis: an open trial evaluating 9 consecutive patients","volume":"51","author":"Kreuter A","year":"2004","unstructured":"Kreuter A, Gambichler T, Breuckmann F, Bechara FG, Rotterdam S, St\u00fccker M, Altmeyer P. Pulsed intravenous immunoglobulin therapy in livedoid vasculitis: an open trial evaluating 9 consecutive patients. J Am Acad Dermatol. 2004, 51:574-9. 10.1016\/j.jaad.2004.05.003","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.05.039","article-title":"Efficacy of intravenous immunoglobulins in livedoid vasculopathy: long-term follow-up of 11 patients","volume":"71","author":"Monshi B","year":"2014","unstructured":"Monshi B, Posch C, Vujic I, Sesti A, Sobotka S, Rappersberger K. Efficacy of intravenous immunoglobulins in livedoid vasculopathy: long-term follow-up of 11 patients. J Am Acad Dermatol. 2014, 71:738-44. 10.1016\/j.jaad.2014.05.039","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2965","article-title":"Livedoid vasculopathy: a French observational study including therapeutic options","volume":"98","author":"Gardette E","year":"2018","unstructured":"Gardette E, Moguelet P, Bouaziz JD, et al.. Livedoid vasculopathy: a French observational study including therapeutic options. Acta Derm Venereol. 2018, 98:842-7. 10.2340\/00015555-2965","journal-title":"Acta Derm Venereol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012476","article-title":"Hydroxychloroquine in rheumatic autoimmune disorders and beyond","volume":"12","author":"Nirk EL","year":"2020","unstructured":"Nirk EL, Reggiori F, Mauthe M. Hydroxychloroquine in rheumatic autoimmune disorders and beyond. EMBO Mol Med. 2020, 12:e12476. 10.15252\/emmm.202012476","journal-title":"EMBO Mol Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/365638-autoimmune-associated-livedoid-vasculopathy-response-to-immunomodulatory-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T02:23:45Z","timestamp":1758335025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/365638-autoimmune-associated-livedoid-vasculopathy-response-to-immunomodulatory-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.92748","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,19]]}}}